(11) | Registration Number: | P20250199 (Validated european patent) | |
(21) | File number: | P20250199T |
(22) | Date of filing the request: | 17.02.2025 |
(45) | Patent Publication Date and Gazette Number: | 11.04.2025 |
(54) | English Title: | BISPECIFIC ANTI-BCMA X ANTI-CD3 ANTIBODIES AND USES THEREOF |
(96) | Number of the European patent application: | EP 19749096.4, 18.07.2019 | |
(97) | Publication data of the European patent application: | EP 3823664, 26.05.2021, 202121, en | |
(97) | Publication data of the European patent: | EP 3823664, 08.01.2025, 202502, en | |
(51) | IPC: | A61K 39/00 (2006.01) |
| | A61P 35/02 (2006.01) |
| | C07K 16/28 (2006.01) |
(73) | Holder(s): | 1. | Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591-6707, US |
| |
(72) | Inventor(s): | 1. | Eric Smith, New York, 10591, US |
| |
| 2. | Kara Olson, New York, 10591, US |
| |
| 3. | Frank Delfino, New York, 10591, US |
| |
| 4. | David Dilillo, New York, 10591, US |
| |
| 5. | Jessica Kirshner, New York, 10591, US |
| |
| 6. | Olga Sineshchekova, New York, 10591, US |
| |
| 7. | Qian Zhang, New York, 10591, US |
| |
(74) | Representative: | Odvjetnik Tomislav Hadžija, u suradnji sa DENNEMEYER & ASSOCIATES, BCI- Business Center International - 1. kat, Miramarska cesta 24, 10000 Zagreb, HR
|
(30) | Priority Data: | (31) | 201962793645 P | | (32) | 17.01.2019 | | (33) | US | | 201862750968 P | | | 26.10.2018 | | | US | | 201862700596 P | | | 19.07.2018 | | | US |
|
(86) | PCT Application Number and Date | PCT/US2019042447; 18.07.2019 |
(87) | PCT Publication Number and Date | WO2020018820; 23.01.2020 |
(46) | Publication Date of Translation of a European Patent Claims and the Gazette Number: | 11.04.2025 |
|
|